Filings news · BMY
Bristol Myers Squibb filings
Notes on Bristol Myers Squibb's new 8-K reports, insider trades on Form 4, and large-holder reports. For the business itself, see the Bristol Myers Squibb company file.
- Oct 54:18 PM ET
Form 4
Bristol Myers Squibb General Counsel Cari Gallman reports exercising or converting 4,559 shares
The filing reports 4,559 shares in an exercise or conversion of a derivative security (code M); and 2,332 shares withheld to pay the exercise price or tax (code F).
- Oct 24:26 PM ET
Form 4
Bristol Myers Squibb director Phyllis R. Yale reports an award of about 561 deferred share units
The filing reports about 561 deferred share units in a grant or award (code A).
- Oct 24:25 PM ET
Form 4
Bristol Myers Squibb director Theodore R. Samuels, Ii. reports an award of about 821 deferred share units
The filing reports about 821 deferred share units in a grant or award (code A).
- Oct 24:24 PM ET
Form 4
Bristol Myers Squibb director Derica W. Rice reports an award of about 621 deferred share units
The filing reports about 621 deferred share units in a grant or award (code A).
- Oct 24:23 PM ET
Form 4
Bristol Myers Squibb director Michael R. McMullen reports an award of about 561 deferred share units
The filing reports about 561 deferred share units in a grant or award (code A).
- Oct 24:22 PM ET
Form 4
Bristol Myers Squibb director Peter J. Arduini reports an award of about 561 deferred share units
The filing reports about 561 deferred share units in a grant or award (code A).